Another important development in this litigation is that the judge has now scheduled four bellwether trials in cases that have been filed against Boston Scientific Corp. (MDL-2326).
The first of two trials involving allegations with Boston Scientific's Pinnacle transvaginal mesh will begin Feb. 11, 2014 and trials involving the company's Obtryx mesh will begin June 17, 2014, according to the court file.
"Bellwether trials are extremely important because they allow attorneys for both sides to test the strengths and weaknesses of their cases and move the litigation forward," said Resource4thePeople.
"Consumers who may have similar allegations should also be aware that even though trial dates have been set in these cases that we are still accepting and reviewing claims from women who have not yet filed lawsuits."
The lawsuits involve allegations that mesh products that were implanted in women’s bodies to treat pelvic organ prolapse or incontinence failed and caused them to suffer serious side effects, including infections, organ damage, vaginal pain and other health problems, according to the court files.
Last month, in bellwether trials involving transvaginal mesh manufactured by C.R. Bard Inc., a jury found the company liable for $2 million in damages in one case** and Bard settled another as the trial was scheduled to begin.***
The $2 million in damages was awarded to a Georgia nurse who claimed that a Bard Avaulta Plus mesh implant she had in 2009 was defective and caused her to suffer serious health problems, including several corrective surgeries, according to the court file.
In the other case, Bloomberg News reported**** on Aug. 21, 2013 that attorneys for Wanda Queen of North Carolina told the ju
Copyright©2012 Vocus, Inc.
All rights reserved